{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:00:34Z","timestamp":1785495634964,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.7759\/cureus.113710","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:34:28Z","timestamp":1785494068000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Profile of Venous Thromboembolism and Applicability of the ThroLy and IMPEDE VTE Risk Scores in Patients With Lymphoma and Multiple Myeloma: A Moroccan Single-Center Retrospective Study"],"prefix":"10.7759","author":[{"given":"Oumayma","family":"Mnafe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmae","family":"Jamlaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"Eddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1313-4","article-title":"Guidance for the prevention and treatment of cancer-associated venous thromboembolism","volume":"41","author":"Khorana AA","year":"2016","unstructured":"Khorana AA, Carrier M, Garcia DA, Lee AY. Guidance for the prevention and treatment of cancer-associated venous thromboembolism. J Thromb Thrombolysis. 2016, 41:81-91. 10.1007\/s11239-015-1313-4","journal-title":"J Thromb Thrombolysis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24466","article-title":"Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients: the ThroLy score","volume":"91","author":"Antic D","year":"2016","unstructured":"Antic D, Milic N, Nikolovski S, et al.. Development and validation of multivariable predictive model for thromboembolic events in lymphoma patients: the ThroLy score. Am J Hematol. 2016, 91:1014-9. 10.1002\/ajh.24466","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25603","article-title":"Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score","volume":"94","author":"Sanfilippo KM","year":"2019","unstructured":"Sanfilippo KM, Luo S, Wang TF, et al.. Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score. Am J Hematol. 2019, 94:1176-84. 10.1002\/ajh.25603","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update","volume":"38","author":"Key NS","year":"2020","unstructured":"Key NS, Khorana AA, Kuderer NM, et al.. Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol. 2020, 38:496-520. 10.1200\/JCO.19.01461","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman GH","year":"2021","unstructured":"Lyman GH, Carrier M, Ay C, et al.. American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv. 2021, 5:927-74.","journal-title":"Blood Adv"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00586-3","article-title":"International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"23","author":"Farge D","year":"2022","unstructured":"Farge D, Frere C, Connors JM, et al.. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol. 2022, 23:334-47. 10.1016\/S1470-2045(21)00586-3","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2405062","article-title":"Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma","volume":"22","author":"Palumbo A","year":"2008","unstructured":"Palumbo A, Rajkumar SV, Dimopoulos MA, et al.. Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia. 2008, 22:414-23. 10.1038\/sj.leu.2405062","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit JA","year":"2015","unstructured":"Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015, 12:464-74. 10.1038\/nrcardio.2015.83","journal-title":"Nat Rev Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2012.1.626","article-title":"Cancer-associated thrombosis: updates and controversies","volume":"2012","author":"Khorana AA","year":"2012","unstructured":"Khorana AA. Cancer-associated thrombosis: updates and controversies. Hematology Am Soc Hematol Educ Program. 2012, 2012:626-30. 10.1182\/asheducation-2012.1.626","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814468","article-title":"Apixaban to prevent venous thromboembolism in patients with cancer","volume":"380","author":"Carrier M","year":"2019","unstructured":"Carrier M, Abou-Nassar K, Mallick R, et al.. Apixaban to prevent venous thromboembolism in patients with cancer. N Engl J Med. 2019, 380:711-9. 10.1056\/NEJMoa1814468","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5482\/ha-1170","article-title":"Epidemiology, risk and outcomes of venous thromboembolism in cancer","volume":"32","author":"Falanga A","year":"2012","unstructured":"Falanga A, Russo L. Epidemiology, risk and outcomes of venous thromboembolism in cancer. Hamostaseologie. 2012, 32:115-25. 10.5482\/ha-1170","journal-title":"Hamostaseologie"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-08-0615","article-title":"Cancer-associated venous thromboembolism: burden, mechanisms, and management","volume":"117","author":"Ay C","year":"2017","unstructured":"Ay C, Pabinger I, Cohen AT. Cancer-associated venous thromboembolism: burden, mechanisms, and management. Thromb Haemost. 2017, 117:219-30. 10.1160\/TH16-08-0615","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30514-1","article-title":"Deep vein thrombosis and pulmonary embolism","volume":"388","author":"Di Nisio M","year":"2016","unstructured":"Di Nisio M, van Es N, Buller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016, 388:3060-73. 10.1016\/S0140-6736(16)30514-1","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1700365","article-title":"Thrombophilia testing and venous thrombosis","volume":"377","author":"Connors JM","year":"2017","unstructured":"Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med. 2017, 377:1177-87. 10.1056\/NEJMra1700365","journal-title":"N Engl J Med"},{"key":"ref15","unstructured":"Cancer-associated venous thromboembolic disease, NCCN guidelines version 1.2026. (2025). https.\/\/www.nccn.org\/guidelines\/guidelines-detail?category=3&id=1423."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506668-clinical-profile-of-venous-thromboembolism-and-applicability-of-the-throly-and-impede-vte-risk-scores-in-patients-with-lymphoma-and-multiple-myeloma-a-moroccan-single-center-retrospective-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:34:29Z","timestamp":1785494069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506668-clinical-profile-of-venous-thromboembolism-and-applicability-of-the-throly-and-impede-vte-risk-scores-in-patients-with-lymphoma-and-multiple-myeloma-a-moroccan-single-center-retrospective-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.113710","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}